Suzhou Fushilai Pharmaceutical Co., Ltd.

SZSE:301258 Stock Report

Market Cap: CN¥2.3b

Suzhou Fushilai Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 301258?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders3,410,0003.74%
Institutions8,869,9259.73%
General Public23,673,47526%
Private Companies55,200,00060.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 74.02% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
60.6%
Suzhou Fushilai Technology Service Development Center (Limited Partnership)
55,200,000CN¥1.4b0%no data
3.22%
Suzhou Guofa Orient Venture Capital Management Co., Ltd.
2,931,900CN¥72.9m0%100.0%
2.42%
Yongxing Wang
2,208,000CN¥54.9m0%no data
1.93%
Suzhou International Development Venture Capital Holding Co., Ltd.
1,758,800CN¥43.7m0%100.0%
1.05%
Galaxy Asset Management Co. Ltd.
959,950CN¥23.9m245%0.07%
0.72%
Wentian Private Fund Management (Guangzhou) Co., Ltd
652,900CN¥16.2m0%no data
0.38%
Jiangang Lu
350,000CN¥8.7m0%no data
0.36%
Barclays PLC Private Banking & Investment Banking Investment
331,660CN¥8.2m0%no data
0.33%
Guiying Qian
300,000CN¥7.5m0%no data
0.3%
Shenyin Wanguo Asset Management (Asia) Limited
275,834CN¥6.9m0%0.05%
0.28%
JPMorgan Chase & Co, Brokerage and Securities Investments
253,500CN¥6.3m0%no data
0.26%
Goldman Sachs Group, Investment Banking and Securities Investments
234,851CN¥5.8m0%no data
0.22%
UBS Asset Management AG
200,574CN¥5.0m0%no data
0.22%
Aijin Bian
200,000CN¥5.0m0%no data
0.22%
Everbright Asset Management Co., Ltd.
196,371CN¥4.9m0%0.06%
0.21%
Yi Qian
190,000CN¥4.7m0%no data
0.21%
Huatai Securities (Shanghai) Asset Management Co., Ltd.
188,293CN¥4.7m0%0.04%
0.21%
Everbright Pramerica Fund Management Co. Ltd.
187,342CN¥4.7m0%0.04%
0.2%
Suzhou Longju Dongfang Investment Management Enterprise (LP)
178,400CN¥4.4m0%100.0%
0.19%
CITIC Securities Company Limited, Asset Management Arm
173,849CN¥4.3m0%no data
0.19%
Morgan Stanley, Investment Banking and Brokerage Investments
173,603CN¥4.3m0%no data
0.18%
Xiangyun Qian
162,000CN¥4.0m0%no data
0.17%
China Southern Asset Management Co., Ltd.
155,900CN¥3.9m0%no data
0.0047%
Harvest Fund Management Co. Ltd.
4,284CN¥106.5k0%no data
0.003%
Dacheng Fund Management Co., Ltd.
2,726CN¥67.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 06:46
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Suzhou Fushilai Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution